pimavanserin Nuplazid
Selected indexed studies
- Trial of Pimavanserin in Dementia-Related Psychosis. (N Engl J Med, 2021) [PMID:34289275]
- Pimavanserin. (, 2012) [PMID:31643450]
- Pimavanserin. (Drugs Today (Barc), 2015) [PMID:26744739]
_Worker-drafted node — pending editorial review._
Connections
pimavanserin Nuplazid is a side effect of
Sources
- Pimavanserin. (2012) pubmed
- Trial of Pimavanserin in Dementia-Related Psychosis. (2021) pubmed
- Pimavanserin. (2015) pubmed
- Pimavanserin. (2006) pubmed
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. (2014) pubmed
- Pimavanserin. (2026) pubmed
- Management of Behavioral and Psychological Symptoms of Dementia. (2019) pubmed
- New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. (2022) pubmed
- Pimavanserin: First Global Approval. (2016) pubmed
- Psychotic Disorders in the Elderly: Diagnosis, Epidemiology, and Treatment. (2022) pubmed